PHIO FY 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$138,000+820.0% YoY

Gross Profit

-$4M-3034.8% margin

Operating Income

-$7M-5336.2% margin

Net Income

-$7M-5333.3% margin

EPS (Diluted)

$-6218.35

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$282,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$2M

Stockholders' Equity

$14M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138,000	$15,000	+820.0%
Gross Profit	-$4M	-$5M	+21.8%
Operating Income	-$7M	-$14M	+47.6%
Net Income	-$7M	-$12M	+40.9%